Recently, we and others described optimal culture conditions for the in vitro generation of human CD34 + progenitor cell-derived DC (PC-DC) [3] [4] [5] as well as their immature counterparts, Langerhans' cells (PC-LC). 6 Both types of DC were characterized by their veiled morphology, their potent capacity to stimulate alloreactive T cells, and a unique pattern of surface markers -including substantial levels of major histocompatibility complex (MHC), costimulatory and adhesion molecules -depending on their maturation stage. [3] [4] [5] [6] Furthermore, similar DC can easily be generated from peripheral blood monocytes, designated Mo-DC. 7 Given their role in antigen presentation and tumor immunity in vivo, 8 human DC constitute a highly attractive target for gene therapy. One of the remaining chal-lenges in current immunotherapy protocols is to load DC with the correct antigens for stimulation of major histocompatibility complex (MHC) class I-restricted antitumoral immunity. 9 The endogenous synthesis requirement for access to the MHC class I pathway could be bypassed through transduction of relevant genes encoding antigenic proteins. Such tumor gene-modified DC could then be used as vaccines or would enable the in vitro generation of autologous tumor-specific CTL for adoptive immunotherapy. 10 Recently, several authors reported the feasibility of retroviral transduction of human dendritic cells in vitro. [11] [12] [13] Although nonviral transfection of Mo-DC has also been reported, levels of gene transfer were low. 14, 15 In addition, no data exist on the efficiency of nonviral transfection of PC-DC or PC-LC.
Here, we describe for the first time nonviral gene transfer by lipofection and electroporation of PC-DC and PC-LC. Using flow cytometric analysis of a 'humanized' redshifted green fluorescent protein (GFP) reporter gene, we demonstrate that electroporation is far superior to lipofection for introduction of plasmid DNA into PC-DC and PC-LC. In addition, we observed different transfection characteristics for each type of DC and obtained highefficiency gene transfer by electroporation in PC-DC and PC-LC but not in Mo-DC.
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Results
Optimization of transfection
In our attempt to transfect mature human DC, we routinely used Mo-DC, PC-DC and PC-LC obtained after 5, 10 and 21 days of culture, respectively. Since we found no significant differences in gene transfer efficiency and viability after transfection between bone marrow (BM) and cord blood (CB) DC/LC progeny (data not shown), results from BM-and CB-derived PC-DC and PC-LC were pooled in all experiments. Using flow cytometric analysis, viable transfected cells were gated out based on their ethidium bromide exclusion and/or scatter profile and GFP analysis was used to determine transfection efficiency in this gated population. We first examined lipofection, using three different cationic lipids: Lipofect-AMINE, DOSPER and DMRIE-C. After careful optimization, only DMRIE-C-mediated lipofection resulted in detectable levels of GFP expressing cells. Optimal transfection efficiencies of 2% and 1% in PC-LC and PC-DC, respectively, were obtained with 9 l DMRIE-C. However, transfection efficiency in Mo-DC was relatively lower at this optimal concentration, since less than 1% GFP expressing cells were barely detected above background levels (Table 1) . Transfection with DOSPER or LipofectAMINE gave no GFP expression in any type of cultured DC (Table 1) .
In a next approach, electroporation was used as a means to introduce plasmid DNA into DC. Table 1 summarizes the efficiency of gene transfer at several electrical settings in three different types of cultured DC 1 day after electroporation. Whereas a high voltage pulse of 1000 V at low capacitance (25 F) resulted in only little or no transfection, substantial GFP fluorescence was always obtained in PC-DC and PC-LC electroporated at lower voltage pulses ranging from 240 to 350 V, in combination with a relative high capacitance (750-1050 F). Since cell viability decreased with increasing voltage, the optimal voltage of 300 V was lowered to 250 V. To compensate for this, capacitance was increased from 1050 F to 1500 F. Decreasing the volume in the electroporation cuvette or further increasing capacitance to 3000 F only led to longer pulse times and excessive cell death (data not shown). Therefore, 250 V and 1500 F were chosen as optimal electrical parameters for transfection of PC-LC and PC-DC ( Table 1) .
Comparison of electroporation efficiency in three distinct types of DC All three types of DC electroporated at optimum settings (250 V, 1500 F) differed significantly in their respective transfectability, as depicted in Figure 1 . GFP analysis of viable electroporated PC-LC, PC-DC and Mo-DC cultures revealed a gene transfer efficiency of 15.8 ± 1.4%, 11.8 ± 1% and 1.2 ± 0.5%, and a viability of 60 ± 6%, 55 ± 8% and 40 ± 5%, respectively, 1 day after electroporation ( Figure 
Analysis of electroporated PC-DC and PC-LC
Due to the presence of other hematopoietic cell types in DC cultures, particularly monocytes and granulocytes, we performed fluorescence microscopy to distinguish GFP + DC-like cells from GFP + cells lacking typical morphologic DC features ( Figure 3a) . Because of the enhanced fluorescent properties of the humanized redshifted GFP variant, bright GFP + cells are detectable even without shutting off the transmitted light (as depicted in Figure 3a ). However, the total percentage of GFP + cells is underestimated on this photograph due to these combined light conditions. Furthermore, CD1a was used as a surface marker for LC as opposed to DC development and was simultaneously assessed with GFP fluorescence in viable PC-LC and PC-DC, in order to ascertain the presence of double-positive CD1a + GFP + DC. A representative example for PC-LC is shown in Figure 3b . The ratio of GFP + cells within the total CD1a + population was similar to the total percentage of GFP + cells within the viable population, indicating that CD1a + LC are equally as transfectable as the total cell population. Similar findings were observed in PC-DC cultures (data not shown).
Kinetic analysis of GFP expression after electroporation showed a rapid induction of GFP expression already after 8-10 h. GFP fluorescence peaked at approximately 24 h after electroporation in both types of DC. In PC-DC, the percentage of GFP + cells rapidly decreased by more than 50% at 48 h after transfection (Figure 4) . After 96 h, the number of GFP expressing cells decreased to 0.8 ± 0.5%. GFP expression in PC-LC was somewhat more persistent than in PC-DC as we detected still more than 70% of peak values after 48 h, and the percentage of GFP + cells was still 1.2 ± 0.4% after 1 week (Figure 4) .
We also tested whether the process of electroporation had a possible deteriorating effect on the allostimulatory capacity of PC-DC and PC-LC assayed by a mixed leukocyte reaction (MLR), as described in Materials and methods. However, we found no significant impairment of MLR capacity in GFP-electroporated PC-DC and PC-LC in comparison with non-and mock-electroporated controls (data not shown).
As CD34 + progenitor cells underwent substantial proliferation and persistent maturation towards the LC/DC lineage during culture, 3, 6 we also investigated the effect of performing electroporation at different time-points after the initiation of the PC-DC and PC-LC cultures. In this respect, we clearly observed that the time-point of electroporation during development towards more mature stages of the LC/DC lineage profoundly influenced gene transfer efficiency. As shown in Table 2 , the percentage of GFP expressing cells in both types of dendritic cells decreased significantly when electroporation was performed at later stages during culture. Table 2 also shows a remarkably higher gene transfer efficiency in the early stages of PC-LC culture (days 9 and 12) than of PC-DC culture (days 6 and 8).
Discussion
To date, DC have become a major topic of interest for the development of vaccines for treatment of cancer and infectious diseases. Antigen-pulsed DC have been shown to induce tumor-specific CTL in vitro [16] [17] [18] and elicit therapeutic antitumor immune responses in murine tumor models. 19, 20 Recent evidence also suggests their potential role as human tumor vaccines. 21 Effective antitumoral immunity is mediated by cytotoxic CD8 + T cells that are capable of killing neoplastic cells, provided a tumor-specific peptide is present on MHC class I molecules. 22 To gain access to the MHC class I presentation pathway, antigenic proteins need to be endogenously synthesized or directly introduced into the cytosol, after which processing and presentation on MHC class I molecules occurs. 23 Transfer of full-length cDNA encoding tumor antigens in DC would be an ideal strategy to generate immunogenic peptides which could be tailored by the DC to its own MHC class I molecules, thereby obviating the need to synthesize stringent MHC-restricted tumor peptides for each individual patient. 9 Recently, several reports have shown the feasibility of gene transfer into human DC and advocated the role of genetically engineered DC for cancer immunotherapy. [11] [12] [13] [14] [15] Retroviral transduction of human CD34
+ hematopoietic progenitors and subsequent differentiation into DC resulted in stable expression of the transgene encoding a tumor-associated antigen. 11, 12 These tumor gene-modified PC-DC were effective in eliciting antigen-specific T cell activation. Also, cationic lipid transfection of Mo-DC with a tyrosinase gene led to transgene expression and subsequent stimulation of a tyrosinase-specific CTL clone, but no data on efficiency of this liposome-mediated gene transfer have been reported. 14 In this study, we report for the first time on the efficiency of nonviral gene transfer by lipofection and electroporation into human PC-DC and PC-LC. Transfection efficiency was determined by a humanized redshifted N1-EGFP variant of the GFP reporter gene, encoding an intrinsic green fluorescent protein, allowing detection and real-time monitoring by flow cytometric
Figure 2 Flow cytometric analysis of GFP expression in different types of cultured DC types. Electroporation of mature PC-DC (day 10), PC-LC (day 21) and Mo-DC (day 5) was performed as described in Materials and methods. Flow cytometry was performed 24 h after electroporation. Left: scatter profile of electroporated PC-DC, PC-LC and Mo-DC. Viable cells were gated out based on their scatter profile and ethidium bromide exclusion (upper gate). Right: GFP-fluorescence histograms of gated electroporated cells. Mock-electroporated cells are shown in dashed lines. The M1 region indicates the gated GFP positive cell fraction.
Figure 3 (a) Fluorescence microscopy of GFP-electroporated PC-DC. PC-DC were electroporated at optimal conditions and visualized by fluorescence microscopy 24 h after electroporation directly in liquid culture. Two bright GFP-expressing cells bearing DC-like morphology are indicated (white arrows). Note that this photograph was taken without shutting off the transmitted light to enable morphological detail detection. (b) Identification of CD1a + GFP + double-positive PC-LC. GFP fluorescence was assessed 24 h after electroporation, simultaneously with CD1a-PE fluorescence (FL2 fluorescence) by flow cytometric analysis of viable PC-LC, electroporated at optimal conditions (250 V, 1500 F).
analysis. 24 GFP has previously been shown to be a useful transfection and selection marker for mammalian cells, including DC, 25 allowing cell sorting of transfected cells. Transfection with cationic lipids proved to be a gentle but inefficient technique in all three types of DC. It is possible that the introduced lipid-DNA complexes are subjected to a fast endocytolytic degradation pathway, caused by the high endosomal or lysosomal activities of the DC. 10 However, it appears that even low expression of the introduced gene may be sufficient to activate specific CTL. 14 Electroporation of mature PC-DC, on the other hand, was found to be a rapid, reproducible and efficient method to transfect these antigen presenting cells. Our electroporation efficiency of PC-DC was somewhat lower than the retroviral transduction efficiency in PC-DC and Mo-DC, previously reported by others [11] [12] [13] to be 22-30% and 35-67%, respectively. However, electroporation of nonviral naked DNA offers a safe alternative to, and requires a less complex infrastructure, than virusmediated gene transfer. In addition, transient gene expression by electroporation of antigen encoding plasmid DNA into DC may be sufficient to elicit specific CTL activation, in analogy to what has been reported for lipofection of DC.
14 From this perspective, long-term expression induced by retroviral transduction may not be a prerequisite for a succesful vaccination strategy.
In addition to optimizing electroporation parameters for PC-DC, we evaluated plasmid DNA transfection of PC-LC, which were cultured according to a LC culture system described by Herbst et al. 6 PC-LC are considered to be immature counterparts of DC and can be induced to differentiate to mature DC by the addition of inflammatory stimuli (eg TNF-␣ and lipopolysaccharide). 6, 26 This feature enables genetic manipulation before terminal differentiation to DC which could be favorable for antigen presentation. 27 We found a superior efficacy of gene transfer, as well as a relatively more persistent expression profile in PC-LC, as compared with PC-DC.
Although levels of gene transfer were significantly higher if electroporation was performed at earlier stages of PC-DC and PC-LC culture, this transfection method was still successful at later stages when satisfactory numbers of morphologically, phenotypically and functionally defined PC-DC 3 (day 10) and PC-LC 6 (day 21) were obtained. Interestingly, efficiency of lipofection or electroporation was independent of the source of CD34 + progenitors, ie human bone marrow or cord blood.
As a third type of DC, we evaluated Mo-DC as a target for nonviral gene transfer by lipofection and electroporation. Transfection with cationic lipids was inefficient, which is in line with data reported by other authors. 14, 15 Furthermore, this study shows that the refractoriness of Mo-DC is in striking contrast to the high-efficiency gene transfer by electroporation in PC-DC and PC-LC. It has already been reported that, despite a high degree of morphological and functional similarities, Mo-DC differ from BM-or CB-derived PC-DC both at a cellular and molecular level. 28, 29 In line with these data, we found an additional clear-cut difference in terms of transfectability between these two types of DC.
In conclusion, we demonstrate that PC-DC and PC-LC but not Mo-DC can be effectively gene-modified by electroporation. Moreover, electroporation might be an attractive approach for nonviral introduction of genes encoding tumor antigens or cytokines in PC-DC and PC-LC. Whether such tumor gene-modified DC are capable of eliciting a specific antitumor CTL response is currently under investigation.
Materials and methods
Source of cells
Bone marrow (BM) samples were aspirated by sternal puncture from hematologically normal patients undergoing cardiac surgery after informed consent. Cord blood (CB) was collected from healthy full-term infants, according to institutional guidelines. BM and CB samples were collected in tubes containing 2 ml Iscove's modified Dulbecco's medium (IMDM; Gibco BRL , Paisley, UK), 10% fetal calf serum (FCS; Sera Lab, Sussex, UK) and 5 U/ml preservative-free heparin (Novo Industries, Bagsvaerd, Denmark). Peripheral blood (PB) was obtained from healthy volunteers. Mononuclear cells (MC) were separated on a Lymphocyte Separation Medium density gradient (ICN Biomedicals, Costa Mesa, CA, USA).
CD34
+ cell sorting Mononuclear BM or CB cells were indirectly stained using supernatant of the 43A1 hybridoma (anti-CD34, kindly donated by Dr H-J Bü hring, University of Tü bingen, Germany) 30 and FITC-conjugated rabbit antimouse immunoglobulins (DAKO, Glostrup, Denmark). The CD34-labeled cells were then sorted on a FACStar PLUS cell sorter (Becton Dickinson, Erembodegem, Belgium) equipped with an air-cooled argon ion laser ILT model 5500-A (Ion Laser Technology, Salt Lake City, UT, USA). Sort windows were set to include cells with low side scatter and with positive green fluorescence (CD34 + ). Purities of Ͼ95% were routinely obtained.
Generation of DC Sorted CD34
+ cells were plated at 10 5 cells/ml in 2 ml IMDM, containing 10% FCS, 1% bovine serum albumin (BSA) (Sigma, Bornem, Belgium), penicillin (100 U/ml; Gibco BRL) and streptomycin (100 g/ml; Gibco BRL) and were cultured as described below to generate PC-DC or PC-LC.
PC-DC cultures were cultured as described previously. 3 Briefly, CD34 + cells were supplemented with 100 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF), 2.5 ng/ml tumor necrosis factor (TNF)-␣ and 50 ng/ml stem cell factor (SCF) (all from Boehringer Mannheim, Mannheim, Germany) until day 5; afterwards, SCF was omitted and 1000 U/ml interleukin (IL)-4 (Genzyme, Cambridge, MA, USA) was added for the next 9 days.
For long-term culture of PC-LC, we used the protocol designed by Herbst et al. 6 In brief, CD34 + progenitor cells were first incubated for 8 days in 100 ng/ml IL-3 (kindly provided by Dr SC Clark, Genetics Institute, Cambridge, MA, USA), 100 ng/ml IL-6 (Boehringer Mannheim) and 50 ng/ml SCF, followed by differentiation in GM-CSF (100 ng/ml) and IL-4 (1000 U/ml) for the next 4 weeks.
Mo-DC were generated as described by Romani et al. 7 Briefly, PBMC were resuspended in IMDM-10% FCS and allowed to adhere to plastic dishes. After 2 h at 37°C, the non-adherent fraction was removed and the adherent cells were further cultured with GM-CSF (100 ng/ml) and IL-4 (1000 U/ml) for 5-7 days.
Transfection of DC PC-DC, PC-LC and Mo-DC were routinely transfected after 10, 21 and 5 days of culture respectively, except where indicated. For liposomal gene transfer, 2 × 10 6 cells per transfection were washed once in serum-free growth medium (Opti-MEM, Gibco BRL) without antibiotics. Cells were then resuspended in 0.8 ml Opti-MEM and seeded in a six-well plate. Lipofection with DMRIE-C (Gibco BRL), LipofectAMINE (Gibco BRL) and DOSPER (Boehringer Mannheim) was performed according to the manufacturer's instructions. Briefly, increasing amounts of DMRIE-C (1-12 l), LipofectAMINE (2-25 l) and DOSPER (1-20 l) were diluted in 100 l Opti-MEM and mixed with 4 g of plasmid DNA, also diluted in 100 l Opti-MEM. After incubation for 30 min at room temperature to allow formation of DNA-liposome complexes, the lipid-DNA solution was added to the cells, mixed gently and incubated for 4 h at 37°C, 5% CO 2 and 7.5% O 2 . Following incubation, 1 ml of complete DC medium was added to each well. Gene activity was assayed 1 day after transfection.
For electroporation, cells were harvested, washed once and resuspended in X-vivo 15 medium (BioWhittaker, Walkersville, MD, USA) to a final concentration of 6-10 × 10 6 cells/ml. Then, 0.5 ml of cell suspension was mixed with 20 g of plasmid DNA (0.5 g/l) in a 0.4 cm electroporation cuvette, incubated for 1 min at room temperature, and electroporated with an Easyject Plus apparatus (Eurogentec, Seraing, Belgium), which delivers exponential electropulses. Electroporation volume and DNA quantity was kept constant at 0.5 ml and 20 g, respectively, throughout all experiments. Various voltages and capacitances were used to optimize electroporation. After shocking, cells were immediately resuspended in 3.5 ml fresh complete DC medium and incubated in six-well plates at 37°C, 5% CO 2 and 7.5% O 2 . Viability of cells after transfection was determined by ethidium bromide exclusion.
GFP analysis
A red-shifted humanized variant of the GFP gene, driven by the CMV-IE promoter, called N1-EGFP was purchased from Clontech (Palo Alto, CA, USA). This mutant GFP variant emits a bright green fluorescence (511 nm) after excitation with blue light (488 nm). 19 Plasmids were transformed in E. coli (DH5␣) and purified on Qiagen-500 columns (Qiagen, Chatsworth, CA, USA). For detection of GFP expression, cells were observed by an inverted fluorescence microscope (Fluovert, Leitz, Germany) and/or washed once in IMDM and analyzed on a FACScan analytical flow cytometer (Becton Dickinson).
Immunophenotyping of DC Immunophenotyping was performed as described previously. 3 The following monoclonal antibodies were used: CD1a-fluorescein isothiocyanate (FITC) (Ortho Diagnostic Systems, Beerse, Belgium), CD1a-phycoerythrin (PE) (Caltag Laboratories, San Francisco, CA, USA), CD14-PE, HLA-DR-PE, CD4-PE, CD80-PE (Becton Dickinson), CD40-FITC (BioSource, Zoersel, Belgium), CD86-PE (PharMingen, San Diego, CA) and CD13-FITC (DAKO). Nonreactive antibodies of the same isotype were used as controls: mouse IgG1-FITC, IgG1-PE and IgG2a-PE (Becton Dickinson).
Allogeneic MLR Allostimulation of CD4
+ T cells was done as previously described. 3 Briefly, transfected and nontransfected stimulator PC-DC or PC-LC were harvested 24 h after electroporation, resuspended at 10 5 /ml and irradiated (60 Gy). Allostimulation was set up in quadruplicate, using 10 5
CD4
+ responder T cells and serial dilutions of stimulator cells in 200 l of complete medium. As negative controls, 10 5 responder cells or 10 4 stimulator cells were cultured in medium alone. At day 5, each well was pulsed with 0.4 Ci 3 H-thymidine (Amersham Life Science, Buckinghamshire, UK), harvested on glass filter paper 8 h later and isotope incorporation measured by liquid scintillation counting.
Statistical analysis
Student's t test was used to determine statistical significance. A value of P р 0.05 was considered significant.
